Avails Medical awarded additional $1.7M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy
MENLO PARK, Calif., Sept. 1, 2022 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™) announced today the transition to the next phase…
Read More
Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT™
MENLO PARK, Calif. , Aug. 15, 2022 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced today the commencement of U.S. pivotal clinical…
Read More
Avails Medical’s eQUANT paper ‘Novel electronic biosensor for automated inoculum preparation to accelerate antimicrobial susceptibility testing’ published in Scientific Reports
MENLO PARK, Calif., June 1, 2021 /PRNewswire/ – Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today the publication of a new peer-reviewed paper…
Read More
Avails Medical awarded $2.5M in CARB-X funding for the development of its rapid antibiotic susceptibility testing device to identify the most effective antibiotic therapy
MENLO PARK, Calif., February 1, 2021 /PRNewswire/ -- Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (AST) announced today it was awarded up to $2.5M in…
Read More
EVENTS
2021 Events Coming Soon
Scheduling for conferences in 2021.
MEDIA
Recent Posts / View All Posts
Hightech oder Hoelle Leben im Silicon Valley Avails has been featured on German TV (VOX) documentary about the Silicon Valley
